{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:36:34Z","timestamp":1793381794490,"version":"4.5.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T00:00:00Z","timestamp":1492560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009844","name":"PA Research Foundation","doi-asserted-by":"publisher","award":["2013003030"],"award-info":[{"award-number":["2013003030"]}],"id":[{"id":"10.13039\/100009844","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Queensland Head and Neck Cancer Centre"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0175755","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T13:54:55Z","timestamp":1492610095000},"page":"e0175755","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients"],"prefix":"10.1371","volume":"12","author":[{"given":"Richard","family":"Linedale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Campbell","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid T.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle G.","family":"Ganko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict J.","family":"Panizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4078-5653","authenticated-orcid":true,"given":"Graham R.","family":"Leggatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11912-005-0042-9","article-title":"High-risk non-melanoma skin cancer of the head and neck","volume":"7","author":"SY Lai","year":"2005","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"ref2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-0036-1579778","article-title":"An Overview of Head and Neck Malignancy with Perineural Spread","volume":"77","author":"BJ Panizza","year":"2016","journal-title":"J Neurol Surg B Skull Base"},{"issue":"1","key":"ref3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.oraloncology.2014.10.004","article-title":"Perineural growth in head and neck squamous cell carcinoma: a review","volume":"51","author":"J Roh","year":"2015","journal-title":"Oral Oncol"},{"issue":"2","key":"ref4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0036-1571836","article-title":"The Imaging of Large Nerve Perineural Spread","volume":"77","author":"M Gandhi","year":"2016","journal-title":"J Neurol Surg B Skull Base"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/hed.21470","article-title":"Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing "targeted" MRI with the histologic findings following surgery","volume":"33","author":"MR Gandhi","year":"2011","journal-title":"Head Neck"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ajd.12314","article-title":"Management of squamous cell and basal cell carcinomas of the head and neck with perineural invasion","volume":"57","author":"A Gupta","year":"2016","journal-title":"Australas J Dermatol"},{"issue":"11","key":"ref7","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/hed.21986","article-title":"Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck","volume":"34","author":"B Panizza","year":"2012","journal-title":"Head Neck"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/hed.23982","article-title":"Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma","volume":"38","author":"TA Warren","year":"2016","journal-title":"Head Neck"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.oraloncology.2014.09.006","article-title":"Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study","volume":"51","author":"GT Wolf","year":"2015","journal-title":"Oral Oncol"},{"issue":"1","key":"ref10","doi-asserted-by":"publisher","first-page":"e965570","DOI":"10.4161\/21624011.2014.965570","article-title":"Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma","volume":"4","author":"S Partlova","year":"2015","journal-title":"Oncoimmunology"},{"issue":"9","key":"ref11","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/annonc\/mdw226","article-title":"The promise of immunotherapy in head and neck squamous cell carcinoma","volume":"27","author":"P Economopoulou","year":"2016","journal-title":"Ann Oncol"},{"issue":"11","key":"ref12","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.1600-0560.2009.01482.x","article-title":"FoxP3 expression is increased in cutaneous squamous cell carcinoma with perineural invasion","volume":"37","author":"B Tallon","year":"2010","journal-title":"J Cutan Pathol"},{"issue":"2","key":"ref13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00262-015-1788-z","article-title":"Galectin-1 is associated with poor prognosis in patients with cutaneous head and neck cancer with perineural spread","volume":"65","author":"S Chawla","year":"2016","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"ref14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2217\/imt.14.58","article-title":"Overcoming tumor-mediated immunosuppression","volume":"6","author":"HA Schlosser","year":"2014","journal-title":"Immunotherapy"},{"issue":"6230","key":"ref15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"P Sharma","year":"2015","journal-title":"Science"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma","volume":"373","author":"J Larkin","year":"2015","journal-title":"N Engl J Med"},{"issue":"101","key":"ref17","first-page":"341","article-title":"Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trials","volume":"18","author":"JL Godwin","year":"2014","journal-title":"Discov Med"},{"issue":"10","key":"ref18","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1084\/jem.20100637","article-title":"Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients","volume":"207","author":"J Fourcade","year":"2010","journal-title":"J Exp Med"},{"issue":"21","key":"ref19","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.1158\/0008-5472.CAN-11-1487","article-title":"Prospects for TIM3-Targeted Antitumor Immunotherapy","volume":"71","author":"SF Ngiow","year":"2011","journal-title":"Cancer Res"},{"issue":"3","key":"ref20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what's in a name?","volume":"4","author":"DI Godfrey","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"ref21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/onc.2009.416","article-title":"Immune infiltration in human tumors: a prognostic factor that should not be ignored","volume":"29","author":"F Pages","year":"2010","journal-title":"Oncogene"},{"issue":"6","key":"ref22","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","article-title":"The Basis of Oncoimmunology","volume":"164","author":"AK Palucka","year":"2016","journal-title":"Cell"},{"issue":"1","key":"ref23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1189\/jlb.4RU0114-001R","article-title":"Immunosuppressive roles of natural killer T (NKT) cells in the skin","volume":"96","author":"SJ McKee","year":"2014","journal-title":"J Leukoc Biol"},{"issue":"3","key":"ref24","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.4049\/jimmunol.0902191","article-title":"Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production","volume":"184","author":"SR Mattarollo","year":"2010","journal-title":"J Immunol"},{"issue":"12","key":"ref25","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1084\/jem.20051381","article-title":"A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance","volume":"202","author":"M Terabe","year":"2005","journal-title":"J Exp Med"},{"issue":"11","key":"ref26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.it.2007.05.008","article-title":"NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis","volume":"28","author":"M Terabe","year":"2007","journal-title":"Trends Immunol"},{"issue":"4","key":"ref27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00262-014-1519-x","article-title":"PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients","volume":"63","author":"S Sun","year":"2014","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"ref28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00262-013-1503-x","article-title":"Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer","volume":"63","author":"CJ Maine","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.2147\/OTT.S105862","article-title":"PD-L1 expression in human cancers and its association with clinical outcomes","volume":"9","author":"X Wang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"ref30","article-title":"PD-L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis","author":"NA Slater","year":"2016","journal-title":"J Cutan Pathol"},{"issue":"2","key":"ref31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.coi.2011.12.005","article-title":"Tim-3, a negative regulator of anti-tumor immunity","volume":"24","author":"AC Anderson","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"ref32","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/2211-5463.12079","article-title":"Abnormal expression of Tim-3 antigen on peripheral blood T cells is associated with progressive disease in osteosarcoma patients","volume":"6","author":"H Liu","year":"2016","journal-title":"FEBS Open Bio"},{"issue":"10","key":"ref33","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-11-0096","article-title":"Anti-TIM3 antibody promotes T cell IFN-gamma-mediated antitumor immunity and suppresses established tumors","volume":"71","author":"SF Ngiow","year":"2011","journal-title":"Cancer Res"},{"key":"ref34","article-title":"Combination therapy with anti-PD-1, anti-TIM-3, and focal radiation results in regression of murine gliomas","author":"JE Kim","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"12","key":"ref35","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/2326-6066.CIR-15-0097","article-title":"Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors","volume":"3","author":"DS Thommen","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"ref36","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1158\/0008-5472.CAN-11-1620","article-title":"Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape","volume":"72","author":"SR Woo","year":"2012","journal-title":"Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0175755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:23:01Z","timestamp":1540340581000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0175755"}},"subtitle":[],"editor":[{"given":"Sophia N.","family":"Karagiannis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0175755","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]}}}